Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Top Performance

Predictions

buy
Canopy Growth Corp

Start price
Target price
Perf. (%)
€6.44
28.01.22
-
28.01.23
-63.05%
25.10.22

Could be worthwhile Investment >10% per year
melinda 
28.01.22 50%
buy
Sernova Corp.

Start price
Target price
Perf. (%)
€0.73
22.09.22
-
22.10.22
-18.32%
23.10.22

Mooses72 
22.09.22 50%
buy
Sernova Corp.

Start price
Target price
Perf. (%)
€0.88
21.10.21
€10.00
21.10.22
-31.88%
22.10.22

JoshuaWesley 
21.10.21 80%
buy
Canopy Growth Corp

Start price
Target price
Perf. (%)
€2.54
24.07.22
-
24.07.23
-3.78%
15.10.22

quelbe60 
24.07.22 50%
buy
Canopy Growth Corp

Start price
Target price
Perf. (%)
€2.48
11.10.22
-
11.10.23
-1.51%
15.10.22

Global_Player 
11.10.22 50%
sell
Edesa Biotech Inc

Start price
Target price
Perf. (%)
€7.09
15.10.21
-
15.10.22
-86.10%
15.10.22

SimonNash 
15.10.21 100%
buy
Canopy Growth Corp

Start price
Target price
Perf. (%)
€2.91
03.08.22
€3.30
03.08.23
-12.37%
13.10.22

Lower EBIT Margin than peer group
High valuation
Very low/no dividend yield expected
Risky balance sheet
geldnutzer 
03.08.22 50%
buy
Canopy Growth Corp

Start price
Target price
Perf. (%)
€4.29
26.08.22
€6.00
26.08.23
-41.69%
13.10.22

Snowman 
26.08.22 50%
buy
Arbutus Biopharma Corp.

Start price
Target price
Perf. (%)
€2.18
04.09.22
-
04.09.23
-9.84%
01.10.22

Global_Player 
04.09.22 50%
buy
Sienna Senior Living Inc

Start price
Target price
Perf. (%)
€9.70
19.09.22
€14.00
19.09.23
-10.31%
01.10.22

gerihouse_ctm 
19.09.22 70%
buy
Arbutus Biopharma Corp.

Start price
Target price
Perf. (%)
€2.39
03.08.22
€2.80
03.08.23
-14.19%
20.09.22

Differentiated customer and product portfolio
Lower EBIT Margin than peer group
High valuation
Very low/no dividend yield expected
geldnutzer 
03.08.22 50%
sell
Burcon Nutrascience Corp.

Start price
Target price
Perf. (%)
€1.53
19.09.21
-
19.09.22
-75.74%
20.09.22

Probably not worthwhile Investment
Lokrim 
19.09.21 10%
buy
Acasti Pharma Inc.

Start price
Target price
Perf. (%)
€11.77
12.09.21
€15.00
12.09.22
-60.64%
13.09.22

Could be worthwhile Investment >10% per year
melinda 
12.09.21 50%
buy
Bausch Health Companies Inc.

Start price
Target price
Perf. (%)
€5.40
23.08.22
-
23.08.23
29.96%
09.09.22

Capable Management
Probably not worthwhile Investment
Revenue decline/stagnation expected
efeu 
23.08.22 50%
buy
Organigram Holdings Inc.

Start price
Target price
Perf. (%)
€4.16
24.07.22
-
24.07.23
-2.64%
04.09.22

quelbe60 
24.07.22 50%
buy
Aurinia Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€7.85
24.08.22
-
24.08.23
-10.03%
03.09.22

Could be worthwhile Investment >10% per year
Vassago1 
24.08.22 50%
buy
Arbutus Biopharma Corp.

Start price
Target price
Perf. (%)
€2.30
26.08.22
-
26.08.23
-4.98%
03.09.22

Vassago1 
26.08.22 50%
buy
AEterna Zentaris Inc.

Start price
Target price
Perf. (%)
€4.77
07.08.22
-
07.08.23
4.82%
26.08.22

Taurito 
07.08.22 0%
buy
Canopy Growth Corp

Start price
Target price
Perf. (%)
€7.59
08.01.22
€9.00
08.01.23
-43.48%
26.08.22

Snowman 
08.01.22 70%
buy
Sernova Corp.

Start price
Target price
Perf. (%)
€0.86
21.10.21
€7.00
21.10.22
0.93%
13.08.22

Keeskopp 
21.10.21 70%
buy
Fennec Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€4.40
29.11.21
-
29.11.22
45.45%
10.08.22

Could be worthwhile Investment >10% per year
skyrockerZoe 
29.11.21 0%
sell
Xenon Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€26.40
04.10.21
-
04.10.22
45.45%
10.08.22

Could be worthwhile Investment >10% per year
skyrockerZoe 
04.10.21 0%
buy
Aurinia Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€10.81
04.07.22
-
04.07.23
-24.63%
06.08.22

Could be worthwhile Investment >10% per year
Vassago1 
04.07.22 50%
sell
Bausch Health Companies Inc.

Start price
Target price
Perf. (%)
€8.45
11.07.22
-
11.07.23
-39.77%
04.08.22

Capable Management
Probably not worthwhile Investment
Revenue decline/stagnation expected
efeu 
11.07.22 50%
sell
Arbutus Biopharma Corp.

Start price
Target price
Perf. (%)
€2.37
28.04.22
€2.00
28.04.23
0.74%
03.08.22

Differentiated customer and product portfolio
Lower EBIT Margin than peer group
High valuation
Very low/no dividend yield expected
geldnutzer 
28.04.22 50%